Arch Biopartners, Inc. (ARCH.V)
1.03
-0.04
(-3.74%)
CAD |
TSXV |
Aug 26, 15:59
Arch Biopartners Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2009 | 22.10% |
| December 31, 2008 | 34.18% |
| September 30, 2008 | 14.03% |
| June 30, 2008 | 16.82% |
| March 31, 2008 | 24.50% |
| Date | Value |
|---|---|
| December 31, 2007 | 23.23% |
| September 30, 2007 | 34.72% |
| June 30, 2007 | 50.57% |
| March 31, 2007 | 34.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Innovotech, Inc. | 8.55% |
| Kane Biotech, Inc. | -53.01% |
| Quest PharmaTech, Inc. | -- |
| BriaCell Therapeutics Corp. | -- |
| Vaxil Bio Ltd. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -920.1% |
| Return on Net Operating Assets | -9.33K% |